|
Lilia M. Beauchamp, M.S. - Chemist (Consulting). Ms. Beauchamp received a M.S. in Organic Chemistry from Fordham University. She is experienced in heterocyclic chemistry, especially acyclic nucleoside synthesis. She originally synthesized and developed preparative methods for the antiviral drugs ZOVIRAX® (acyclovir) and VALTREX® (valaciclovir). ZOVIRAX® generated annual sales of a billion dollars in 1994. Beauchamp is the inventor on the primary VALTREX® patent. She is experienced in the fields of antivirals, central nervous system agents, and prodrugs. She is the author of 14 publications including a review on antiviral drugs, 5 abstracts, and 9 United States patents. One of the founders of KPI, she was directly involved in the decision to pursue an area of chemistry that lead to the discovery of KP544, and was the first to synthesize this compound. | 